SCM
THRD

Sio Capital Management’s Third Harmonic Bio THRD Stock Holding History

Sio Capital Management’s Portfolio THRD Stock Details THRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-163,363
Closed -$2.12M – 55
2024
Q2 		$2.12M Hold
163,363
– – 0.57% 29
2024
Q1 		$1.54M Hold
163,363
– – 0.46% 39
2023
Q4 		$1.79M Buy
+163,363
New +$1.29M 0.41% 27

Other funds holding THRD

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
GA
General Atlantic New York $2.91B AUM 24.21% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

Sio Capital Management's THRD Position: Q3 2024 in Review

Sio Capital Management sold out of Third Harmonic Bio (THRD) in Q3 2024, closing a stake of 163,363 shares — an estimated $2.12M sold.

Sio Capital Management first reported a position in THRD in Q4 2023 and held it in 3 quarters. The position peaked at $2.12M in Q2 2024. 85 funds tracked by Wall St. Rank hold THRD as of Q3 2024.

  • Sio Capital Management reported no remaining Third Harmonic Bio position as of Q3 2024 after selling out during the quarter.
  • Sio Capital Management sold 163,363 Third Harmonic Bio shares in Q3 2024, an estimated $2.12M.
  • Sio Capital Management first reported a position in Third Harmonic Bio in Q4 2023 and held it in 3 quarters.
  • Sio Capital Management's Third Harmonic Bio position peaked at $2.12M in Q2 2024.
  • 85 funds tracked by Wall St. Rank held Third Harmonic Bio as of Q3 2024.

Based on Sio Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.